{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T06:35:07Z","timestamp":1767854107307,"version":"3.49.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2022,10,4]],"date-time":"2022-10-04T00:00:00Z","timestamp":1664841600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,10,4]],"date-time":"2022-10-04T00:00:00Z","timestamp":1664841600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100002701","name":"Ministry of Education","doi-asserted-by":"publisher","award":["NRF-2021R1A2C100447111"],"award-info":[{"award-number":["NRF-2021R1A2C100447111"]}],"id":[{"id":"10.13039\/501100002701","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1007\/s12035-022-03033-9","type":"journal-article","created":{"date-parts":[[2022,10,4]],"date-time":"2022-10-04T15:03:00Z","timestamp":1664895780000},"page":"7439-7449","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Rapamycin Cannot Reduce Seizure Susceptibility in Infantile Rats with Malformations of Cortical Development Lacking mTORC1 Activation"],"prefix":"10.1007","volume":"59","author":[{"given":"Minyoung","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eun-Jin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min-Jee","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5986-5258","authenticated-orcid":false,"given":"Mi-Sun","family":"Yum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,10,4]]},"reference":[{"key":"3033_CR1","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1146\/annurev-pathol-052016-100138","volume":"12","author":"PH Iffland","year":"2017","unstructured":"Iffland PH, Crino PB (2017) Focal cortical dysplasia: gene mutations, cell signaling, and therapeutic implications. Annu Rev Pathol 12:547\u2013571. https:\/\/doi.org\/10.1146\/annurev-pathol-052016-100138","journal-title":"Annu Rev Pathol"},{"issue":"Pt B","key":"3033_CR2","doi-asserted-by":"publisher","first-page":"106550","DOI":"10.1016\/j.yebeh.2019.106550","volume":"101","author":"PB Crino","year":"2019","unstructured":"Crino PB (2019) Mechanistic target of rapamycin (mTOR) signaling in status epilepticus. Epilepsy Behav 101(Pt B):106550. https:\/\/doi.org\/10.1016\/j.yebeh.2019.106550","journal-title":"Epilepsy Behav"},{"issue":"7","key":"3033_CR3","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/nrneurol.2016.81","volume":"12","author":"PB Crino","year":"2016","unstructured":"Crino PB (2016) The mTOR signalling cascade: paving new roads to cure neurological disease. Nat Rev Neurol 12(7):379\u2013392. https:\/\/doi.org\/10.1038\/nrneurol.2016.81","journal-title":"Nat Rev Neurol"},{"issue":"2","key":"3033_CR4","doi-asserted-by":"publisher","first-page":"49","DOI":"10.2217\/fnl-2018-0001","volume":"13","author":"JL Griffith","year":"2018","unstructured":"Griffith JL, Wong M (2018) The mTOR pathway in treatment of epilepsy: a clinical update. Future Neurol 13(2):49\u201358. https:\/\/doi.org\/10.2217\/fnl-2018-0001","journal-title":"Future Neurol"},{"issue":"33","key":"3033_CR5","doi-asserted-by":"publisher","first-page":"11441","DOI":"10.1523\/JNEUROSCI.1283-12.2012","volume":"32","author":"MC Weston","year":"2012","unstructured":"Weston MC, Chen H, Swann JW (2012) Multiple roles for mammalian target of rapamycin signaling in both glutamatergic and GABAergic synaptic transmission. J Neurosci 32(33):11441\u201311452. https:\/\/doi.org\/10.1523\/JNEUROSCI.1283-12.2012","journal-title":"J Neurosci"},{"issue":"1","key":"3033_CR6","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1146\/annurev-neuro-071013-014100","volume":"37","author":"SA Buffington","year":"2014","unstructured":"Buffington SA, Huang W, Costa-Mattioli M (2014) Translational control in synaptic plasticity and cognitive dysfunction. Annu Rev Neurosci 37(1):17\u201338. https:\/\/doi.org\/10.1146\/annurev-neuro-071013-014100","journal-title":"Annu Rev Neurosci"},{"issue":"1","key":"3033_CR7","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.nbd.2010.05.024","volume":"40","author":"X Huang","year":"2010","unstructured":"Huang X, Zhang H, Yang J, Wu J, McMahon J, Lin Y, Cao Z, Gruenthal M et al (2010) Pharmacological inhibition of the mammalian target of rapamycin pathway suppresses acquired epilepsy. Neurobiol Dis 40(1):193\u2013199. https:\/\/doi.org\/10.1016\/j.nbd.2010.05.024","journal-title":"Neurobiol Dis"},{"issue":"21","key":"3033_CR8","doi-asserted-by":"publisher","first-page":"6964","DOI":"10.1523\/jneurosci.0066-09.2009","volume":"29","author":"L-H Zeng","year":"2009","unstructured":"Zeng L-H, Rensing NR, Wong M (2009) The mammalian target of rapamycin signaling pathway mediates epileptogenesis in a model of temporal lobe epilepsy. J Neurosci 29(21):6964\u20136972. https:\/\/doi.org\/10.1523\/jneurosci.0066-09.2009","journal-title":"J Neurosci"},{"issue":"11","key":"3033_CR9","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1111\/j.1528-1167.2012.03674.x","volume":"53","author":"T Chachua","year":"2012","unstructured":"Chachua T, Poon KL, Yum MS, Nesheiwat L, DeSantis K, Veliskova J, Velisek L (2012) Rapamycin has age-, treatment paradigm-, and model-specific anticonvulsant effects and modulates neuropeptide Y expression in rats. Epilepsia 53(11):2015\u20132025. https:\/\/doi.org\/10.1111\/j.1528-1167.2012.03674.x","journal-title":"Epilepsia"},{"issue":"17","key":"3033_CR10","doi-asserted-by":"publisher","first-page":"10263","DOI":"10.1073\/pnas.95.17.10263","volume":"95","author":"N Chevassus-Au-Louis","year":"1998","unstructured":"Chevassus-Au-Louis N, Congar P, Represa A, Ben-Ari Y, Gaiarsa JL (1998) Neuronal migration disorders: heterotopic neocortical neurons in CA1 provide a bridge between the hippocampus and the neocortex. Proc Natl Acad Sci U S A 95(17):10263\u201310268","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1-2","key":"3033_CR11","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/S0006-8993(97)01022-6","volume":"777","author":"IM Germano","year":"1997","unstructured":"Germano IM, Sperber EF (1997) Increased seizure susceptibility in adult rats with neuronal migration disorders. Brain Res 777(1-2):219\u2013222","journal-title":"Brain Res"},{"issue":"1","key":"3033_CR12","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1002\/cne.20871","volume":"495","author":"M Paredes","year":"2006","unstructured":"Paredes M, Pleasure SJ, Baraban SC (2006) Embryonic and early postnatal abnormalities contributing to the development of hippocampal malformations in a rodent model of dysplasia. J Comp Neurol 495(1):133\u2013148. https:\/\/doi.org\/10.1002\/cne.20871","journal-title":"J Comp Neurol"},{"issue":"1","key":"3033_CR13","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1097\/00005072-199901000-00010","volume":"58","author":"C Colacitti","year":"1999","unstructured":"Colacitti C, Sancini G, DeBiasi S, Franceschetti S, Caputi A, Frassoni C, Cattabeni F, Avanzini G et al (1999) Prenatal methylazoxymethanol treatment in rats produces brain abnormalities with morphological similarities to human developmental brain dysgeneses. J Neuropathol Exp Neurol 58(1):92\u2013106","journal-title":"J Neuropathol Exp Neurol"},{"issue":"3","key":"3033_CR14","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1055\/s-0035-1552617","volume":"35","author":"PB Crino","year":"2015","unstructured":"Crino PB (2015) Focal cortical dysplasia. Semin Neurol 35(3):201\u2013208. https:\/\/doi.org\/10.1055\/s-0035-1552617","journal-title":"Semin Neurol"},{"issue":"6","key":"3033_CR15","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1097\/00005072-197811000-00001","volume":"37","author":"BH Choi","year":"1978","unstructured":"Choi BH, Lapham LW, Amin-Zaki L, Saleem T (1978) Abnormal neuronal migration, deranged cerebral cortical organization, and diffuse white matter astrocytosis of human fetal brain: a major effect of methylmercury poisoning in utero. J Neuropathol Exp Neurol 37(6):719\u2013733. https:\/\/doi.org\/10.1097\/00005072-197811000-00001","journal-title":"J Neuropathol Exp Neurol"},{"issue":"2","key":"3033_CR16","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1111\/j.1528-1157.2000.tb00148.x","volume":"41","author":"CT Lombroso","year":"2000","unstructured":"Lombroso CT (2000) Can early postnatal closed head injury induce cortical dysplasia. Epilepsia 41(2):245\u2013253. https:\/\/doi.org\/10.1111\/j.1528-1157.2000.tb00148.x","journal-title":"Epilepsia"},{"key":"3033_CR17","doi-asserted-by":"publisher","first-page":"510","DOI":"10.3389\/fnins.2020.00510","volume":"14","author":"M Lee","year":"2020","unstructured":"Lee M, Kim EJ, Woo DC, Shim WH, Yum MS (2020) In vivo MRI successfully reveals the malformation of cortical development in infant rats. Front Neurosci 14:510. https:\/\/doi.org\/10.3389\/fnins.2020.00510","journal-title":"Front Neurosci"},{"key":"3033_CR18","doi-asserted-by":"publisher","first-page":"271","DOI":"10.3389\/fneur.2017.00271","volume":"8","author":"EH Kim","year":"2017","unstructured":"Kim EH, Yum MS, Lee M, Kim EJ, Shim WH, Ko TS (2017) A new rat model of epileptic spasms based on methylazoxymethanol-induced malformations of cortical development. Front Neurol 8:271. https:\/\/doi.org\/10.3389\/fneur.2017.00271","journal-title":"Front Neurol"},{"issue":"9","key":"3033_CR19","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1016\/j.eplepsyres.2014.08.015","volume":"108","author":"MS Yum","year":"2014","unstructured":"Yum MS, Lee M, Ko TS, Velisek L (2014) A potential effect of ganaxolone in an animal model of infantile spasms. Epilepsy Res 108(9):1492\u20131500. https:\/\/doi.org\/10.1016\/j.eplepsyres.2014.08.015","journal-title":"Epilepsy Res"},{"issue":"3","key":"3033_CR20","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1101\/lm.37601","volume":"8","author":"KA Goosens","year":"2001","unstructured":"Goosens KA, Maren S (2001) Contextual and auditory fear conditioning are mediated by the lateral, basal, and central amygdaloid nuclei in rats. Learn Mem 8(3):148\u2013155. https:\/\/doi.org\/10.1101\/lm.37601","journal-title":"Learn Mem"},{"issue":"1","key":"3033_CR21","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1111\/nan.12463","volume":"44","author":"E Marsan","year":"2018","unstructured":"Marsan E, Baulac S (2018) Mechanistic target of rapamycin (mTOR) pathway, focal cortical dysplasia and epilepsy. Neuropathol Appl Neurobiol 44(1):6\u201317. https:\/\/doi.org\/10.1111\/nan.12463","journal-title":"Neuropathol Appl Neurobiol"},{"key":"3033_CR22","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.yebeh.2018.05.014","volume":"85","author":"F Majolo","year":"2018","unstructured":"Majolo F, Marinowic DR, Machado DC, Da Costa JC (2018) MTOR pathway in focal cortical dysplasia type 2: what do we know? Epilepsy Behav 85:157\u2013163. https:\/\/doi.org\/10.1016\/j.yebeh.2018.05.014","journal-title":"Epilepsy Behav"},{"issue":"47","key":"3033_CR23","doi-asserted-by":"publisher","first-page":"76415","DOI":"10.18632\/oncotarget.13001","volume":"7","author":"K Yao","year":"2016","unstructured":"Yao K, Duan Z, Zhou J, Li L, Zhai F, Dong Y, Wang X, Ma Z et al (2016) Clinical and immunohistochemical characteristics of type II and type I focal cortical dysplasia. Oncotarget 7(47):76415\u201376422. https:\/\/doi.org\/10.18632\/oncotarget.13001","journal-title":"Oncotarget"},{"issue":"Pt 6","key":"3033_CR24","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1093\/brain\/awv045","volume":"138","author":"LA Jansen","year":"2015","unstructured":"Jansen LA, Mirzaa GM, Ishak GE, O'Roak BJ, Hiatt JB, Roden WH, Gunter SA, Christian SL et al (2015) PI3K\/AKT pathway mutations cause a spectrum of brain malformations from megalencephaly to focal cortical dysplasia. Brain 138(Pt 6):1613\u20131628. https:\/\/doi.org\/10.1093\/brain\/awv045","journal-title":"Brain"},{"key":"3033_CR25","doi-asserted-by":"publisher","first-page":"151523","DOI":"10.1016\/j.anndiagpath.2020.151523","volume":"46","author":"K Kumari","year":"2020","unstructured":"Kumari K, Sharma MC, Kakkar A, Malgulwar PB, Pathak P, Suri V, Sarkar C, Chandra SP et al (2020) mTOR pathway activation in focal cortical dysplasia. Ann Diagn Pathol 46:151523. https:\/\/doi.org\/10.1016\/j.anndiagpath.2020.151523","journal-title":"Ann Diagn Pathol"},{"key":"3033_CR26","doi-asserted-by":"publisher","unstructured":"Carnero A, Paramio JM (2014) The PTEN\/PI3K\/AKT pathway in vivo, cancer mouse models. Front Oncol 4. https:\/\/doi.org\/10.3389\/fonc.2014.00252","DOI":"10.3389\/fonc.2014.00252"},{"issue":"14","key":"3033_CR27","doi-asserted-by":"publisher","first-page":"5010","DOI":"10.1128\/MCB.20.14.5010-5018.2000","volume":"20","author":"F Vazquez","year":"2000","unstructured":"Vazquez F, Ramaswamy S, Nakamura N, Sellers WR (2000) Phosphorylation of the PTEN tail regulates protein stability and function. Mol Cell Biol 20(14):5010\u20135018. https:\/\/doi.org\/10.1128\/MCB.20.14.5010-5018.2000","journal-title":"Mol Cell Biol"},{"issue":"7","key":"3033_CR28","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1002\/dneu.22595","volume":"78","author":"M Kielbinski","year":"2018","unstructured":"Kielbinski M, Setkowicz Z, Gzielo K, Janeczko K (2018) Profiles of gene expression in the hippocampal formation of rats with experimentally-induced brain dysplasia. Dev Neurobiol 78(7):718\u2013735. https:\/\/doi.org\/10.1002\/dneu.22595","journal-title":"Dev Neurobiol"},{"key":"3033_CR29","doi-asserted-by":"publisher","first-page":"580357","DOI":"10.3389\/fnins.2020.580357","volume":"14","author":"J Jesus-Ribeiro","year":"2020","unstructured":"Jesus-Ribeiro J, Pires LM, Melo JD, Ribeiro IP, Rebelo O, Sales F, Freire A, Melo JB (2020) Genomic and epigenetic advances in focal cortical dysplasia types I and II: a scoping review. Front Neurosci 14:580357. https:\/\/doi.org\/10.3389\/fnins.2020.580357","journal-title":"Front Neurosci"},{"key":"3033_CR30","doi-asserted-by":"publisher","first-page":"11753","DOI":"10.1038\/ncomms11753","volume":"7","author":"LS Hsieh","year":"2016","unstructured":"Hsieh LS, Wen JH, Claycomb K, Huang Y, Harrsch FA, Naegele JR, Hyder F, Buchanan GF et al (2016) Convulsive seizures from experimental focal cortical dysplasia occur independently of cell misplacement. Nat Commun 7:11753. https:\/\/doi.org\/10.1038\/ncomms11753","journal-title":"Nat Commun"},{"issue":"4","key":"3033_CR31","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1038\/nm.3824","volume":"21","author":"JS Lim","year":"2015","unstructured":"Lim JS, Kim WI, Kang HC, Kim SH, Park AH, Park EK, Cho YW, Kim S et al (2015) Brain somatic mutations in MTOR cause focal cortical dysplasia type II leading to intractable epilepsy. Nat Med 21(4):395\u2013400. https:\/\/doi.org\/10.1038\/nm.3824","journal-title":"Nat Med"},{"key":"3033_CR32","doi-asserted-by":"publisher","unstructured":"D'Gama AM, Poduri A (2021) Precision therapy for epilepsy related to brain malformations. Neurotherapeutics. https:\/\/doi.org\/10.1007\/s13311-021-01122-6","DOI":"10.1007\/s13311-021-01122-6"},{"key":"3033_CR33","doi-asserted-by":"publisher","first-page":"108297","DOI":"10.1016\/j.neuropharm.2020.108297","volume":"180","author":"W Theilmann","year":"2020","unstructured":"Theilmann W, Gericke B, Schidlitzki A, Muneeb Anjum SM, Borsdorf S, Harries T, Roberds SL, Aguiar DJ et al (2020) Novel brain permeant mTORC1\/2 inhibitors are as efficacious as rapamycin or everolimus in mouse models of acquired partial epilepsy and tuberous sclerosis complex. Neuropharmacology 180:108297. https:\/\/doi.org\/10.1016\/j.neuropharm.2020.108297","journal-title":"Neuropharmacology"},{"issue":"4","key":"3033_CR34","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1002\/ana.22696","volume":"71","author":"DM Talos","year":"2012","unstructured":"Talos DM, Sun H, Kosaras B, Joseph A, Folkerth RD, Poduri A, Madsen JR, Black PM et al (2012) Altered inhibition in tuberous sclerosis and type IIb cortical dysplasia. Ann Neurol 71(4):539\u2013551. https:\/\/doi.org\/10.1002\/ana.22696","journal-title":"Ann Neurol"},{"key":"3033_CR35","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.nbd.2016.07.014","volume":"95","author":"G Ruffolo","year":"2016","unstructured":"Ruffolo G, Iyer A, Cifelli P, Roseti C, Muhlebner A, van Scheppingen J, Scholl T, Hainfellner JA et al (2016) Functional aspects of early brain development are preserved in tuberous sclerosis complex (TSC) epileptogenic lesions. Neurobiol Dis 95:93\u2013101. https:\/\/doi.org\/10.1016\/j.nbd.2016.07.014","journal-title":"Neurobiol Dis"},{"issue":"Suppl Suppl 2","key":"3033_CR36","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1002\/epi4.12253","volume":"3","author":"C Cepeda","year":"2018","unstructured":"Cepeda C, Levinson S, Yazon VW, Barry J, Mathern GW, Fallah A, Vinters HV, Levine MS, Wu JY (2018) Cellular antiseizure mechanisms of everolimus in pediatric tuberous sclerosis complex, cortical dysplasia, and non-mTOR-mediated etiologies. Epilepsia Open 3(Suppl Suppl 2):180\u2013190. https:\/\/doi.org\/10.1002\/epi4.12253","journal-title":"Epilepsia Open"},{"issue":"2","key":"3033_CR37","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/s0896-6273(00)80540-1","volume":"21","author":"T Ringstedt","year":"1998","unstructured":"Ringstedt T, Linnarsson S, Wagner J, Lendahl U, Kokaia Z, Arenas E, Ernfors P, Ib\u00e1\u00f1ez CF (1998) BDNF regulates reelin expression and Cajal-Retzius cell development in the cerebral cortex. Neuron 21(2):305\u2013315. https:\/\/doi.org\/10.1016\/s0896-6273(00)80540-1","journal-title":"Neuron"},{"key":"3033_CR38","doi-asserted-by":"publisher","unstructured":"Lizarraga SB, Ma L, Maguire AM, van Dyck LI, Wu Q, Ouyang Q, Kavanaugh BC, Nagda D et al (2021) Human neurons from Christianson syndrome iPSCs reveal mutation-specific responses to rescue strategies. Sci Transl Med 13(580). https:\/\/doi.org\/10.1126\/scitranslmed.aaw0682","DOI":"10.1126\/scitranslmed.aaw0682"},{"issue":"8","key":"3033_CR39","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1093\/jnen\/nlw044","volume":"75","author":"DH Zheng","year":"2016","unstructured":"Zheng DH, Guo W, Sun FJ, Xu GZ, Zang ZL, Shu HF, Yang H (2016) Expression of TRPC6 and BDNF in cortical lesions from patients with focal cortical dysplasia. J Neuropathol Exp Neurol 75(8):718\u2013730. https:\/\/doi.org\/10.1093\/jnen\/nlw044","journal-title":"J Neuropathol Exp Neurol"},{"issue":"6","key":"3033_CR40","doi-asserted-by":"publisher","first-page":"e0158150","DOI":"10.1371\/journal.pone.0158150","volume":"11","author":"KM Ku","year":"2016","unstructured":"Ku KM, Weir RK, Silverman JL, Berman RF, Bauman MD (2016) Behavioral phenotyping of juvenile Long-Evans and Sprague-Dawley rats: implications for preclinical models of autism spectrum disorders. PLoS One 11(6):e0158150. https:\/\/doi.org\/10.1371\/journal.pone.0158150","journal-title":"PLoS One"},{"issue":"1","key":"3033_CR41","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1002\/mrm.10497","volume":"50","author":"I Tkac","year":"2003","unstructured":"Tkac I, Rao R, Georgieff MK, Gruetter R (2003) Developmental and regional changes in the neurochemical profile of the rat brain determined by in vivo 1H NMR spectroscopy. Magn Reson Med 50(1):24\u201332. https:\/\/doi.org\/10.1002\/mrm.10497","journal-title":"Magn Reson Med"},{"key":"3033_CR42","first-page":"2673","volume":"18","author":"H Ripps","year":"2012","unstructured":"Ripps H, Shen W (2012) Review: taurine: a \u201cvery essential\u201d amino acid. Mol Vis 18:2673\u20132686","journal-title":"Mol Vis"},{"issue":"3","key":"3033_CR43","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.eplepsyres.2013.01.010","volume":"104","author":"SS Oja","year":"2013","unstructured":"Oja SS, Saransaari P (2013) Taurine and epilepsy. Epilepsy Res 104(3):187\u2013194. https:\/\/doi.org\/10.1016\/j.eplepsyres.2013.01.010","journal-title":"Epilepsy Res"},{"key":"3033_CR44","doi-asserted-by":"publisher","first-page":"883","DOI":"10.2741\/2110","volume":"12","author":"R Rodrigo","year":"2007","unstructured":"Rodrigo R, Felipo V (2007) Control of brain glutamine synthesis by NMDA receptors. Front Biosci 12:883\u2013890. https:\/\/doi.org\/10.2741\/2110","journal-title":"Front Biosci"},{"issue":"12","key":"3033_CR45","doi-asserted-by":"publisher","first-page":"2944","DOI":"10.1093\/cercor\/bhs283","volume":"23","author":"S Bl\u00fcml","year":"2013","unstructured":"Bl\u00fcml S, Wisnowski JL, Nelson MD, Paquette L, Gilles FH, Kinney HC, Panigrahy A (2013) Metabolic maturation of the human brain from birth through adolescence: insights from in vivo magnetic resonance spectroscopy. Cereb Cortex 23(12):2944\u20132955. https:\/\/doi.org\/10.1093\/cercor\/bhs283","journal-title":"Cereb Cortex"},{"issue":"2","key":"3033_CR46","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1007\/s11357-021-00363-9","volume":"43","author":"RA Towner","year":"2021","unstructured":"Towner RA, Gulej R, Zalles M, Saunders D, Smith N, Lerner M, Morton KA, Richardson A (2021) Rapamycin restores brain vasculature, metabolism, and blood-brain barrier in an inflammaging model. Geroscience 43(2):563\u2013578. https:\/\/doi.org\/10.1007\/s11357-021-00363-9","journal-title":"Geroscience"},{"issue":"6","key":"3033_CR47","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1002\/nbm.2913","volume":"26","author":"JJ Morgan","year":"2013","unstructured":"Morgan JJ, Kleven GA, Tulbert CD, Olson J, Horita DA, Ronca AE (2013) Longitudinal 1H MRS of rat forebrain from infancy to adulthood reveals adolescence as a distinctive phase of neurometabolite development. NMR Biomed 26(6):683\u2013691. https:\/\/doi.org\/10.1002\/nbm.2913","journal-title":"NMR Biomed"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-022-03033-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-022-03033-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-022-03033-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,28]],"date-time":"2022-10-28T06:51:50Z","timestamp":1666939910000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-022-03033-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,4]]},"references-count":47,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["3033"],"URL":"https:\/\/doi.org\/10.1007\/s12035-022-03033-9","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,4]]},"assertion":[{"value":"25 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All experiments were approved by the Institutional Animal Care and Use Committee of the Ulsan University College of Medicine and conducted in accordance with the revised Guide for the Care and Use of Laboratory Animals [NIH GUIDE, 8th Edition, 2011].","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}